241 related articles for article (PubMed ID: 16886956)
1. GH peak response to GHRH-arginine: relationship to insulin resistance and other cardiovascular risk factors in a population of adults aged 50-90.
Carmichael JD; Danoff A; Milani D; Roubenoff R; Lesser ML; Livote E; Reitz RE; Ferris S; Kleinberg DL
Clin Endocrinol (Oxf); 2006 Aug; 65(2):169-77. PubMed ID: 16886956
[TBL] [Abstract][Full Text] [Related]
2. The growth hormone (GH) response to the arginine plus GH-releasing hormone test is correlated to the severity of lipid profile abnormalities in adult patients with GH deficiency.
Colao A; Cerbone G; Pivonello R; Aimaretti G; Loche S; Di Somma C; Faggiano A; Corneli G; Ghigo E; Lombardi G
J Clin Endocrinol Metab; 1999 Apr; 84(4):1277-82. PubMed ID: 10199767
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone deficiency predicts cardiovascular risk in young adults treated for acute lymphoblastic leukemia in childhood.
Link K; Moëll C; Garwicz S; Cavallin-Ståhl E; Björk J; Thilén U; Ahrén B; Erfurth EM
J Clin Endocrinol Metab; 2004 Oct; 89(10):5003-12. PubMed ID: 15472198
[TBL] [Abstract][Full Text] [Related]
4. Effects of single nightly injections of growth hormone-releasing hormone (GHRH 1-29) in healthy elderly men.
Vittone J; Blackman MR; Busby-Whitehead J; Tsiao C; Stewart KJ; Tobin J; Stevens T; Bellantoni MF; Rogers MA; Baumann G; Roth J; Harman SM; Spencer RG
Metabolism; 1997 Jan; 46(1):89-96. PubMed ID: 9005976
[TBL] [Abstract][Full Text] [Related]
5. Lower growth hormone and higher cortisol are associated with greater visceral adiposity, intramyocellular lipids, and insulin resistance in overweight girls.
Misra M; Bredella MA; Tsai P; Mendes N; Miller KK; Klibanski A
Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E385-92. PubMed ID: 18544645
[TBL] [Abstract][Full Text] [Related]
6. The natural history of partial growth hormone deficiency in adults: a prospective study on the cardiovascular risk and atherosclerosis.
Colao A; Di Somma C; Spiezia S; Rota F; Pivonello R; Savastano S; Lombardi G
J Clin Endocrinol Metab; 2006 Jun; 91(6):2191-200. PubMed ID: 16537686
[TBL] [Abstract][Full Text] [Related]
7. Body fat mass is a strong and negative predictor of peak stimulated growth hormone and bone mineral density in healthy adolescents during transition period.
Perotti M; Perra S; Saluzzi A; Grassi G; Pincelli AI
Horm Metab Res; 2013 Sep; 45(10):748-53. PubMed ID: 23913118
[TBL] [Abstract][Full Text] [Related]
8. Improvement in insulin sensitivity without concomitant changes in body composition and cardiovascular risk markers following fixed administration of a very low growth hormone (GH) dose in adults with severe GH deficiency.
Yuen KC; Frystyk J; White DK; Twickler TB; Koppeschaar HP; Harris PE; Fryklund L; Murgatroyd PR; Dunger DB
Clin Endocrinol (Oxf); 2005 Oct; 63(4):428-36. PubMed ID: 16181235
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone secretion and leptin in morbid obesity before and after biliopancreatic diversion: relationships with insulin and body composition.
De Marinis L; Bianchi A; Mancini A; Gentilella R; Perrelli M; Giampietro A; Porcelli T; Tilaro L; Fusco A; Valle D; Tacchino RM
J Clin Endocrinol Metab; 2004 Jan; 89(1):174-80. PubMed ID: 14715846
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men.
Corpas E; Harman SM; Piñeyro MA; Roberson R; Blackman MR
J Clin Endocrinol Metab; 1992 Aug; 75(2):530-5. PubMed ID: 1379256
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone (GH) status is an independent determinant of serum levels of cholesterol and triglycerides in healthy adults.
Vahl N; Klausen I; Christiansen JS; Jørgensen JO
Clin Endocrinol (Oxf); 1999 Sep; 51(3):309-16. PubMed ID: 10469010
[TBL] [Abstract][Full Text] [Related]
12. Preliminary data on the relationship between circulating levels of Sirtuin 4, anthropometric and metabolic parameters in obese subjects according to growth hormone/insulin-like growth factor-1 status.
Savastano S; Di Somma C; Colao A; Barrea L; Orio F; Finelli C; Pasanisi F; Contaldo F; Tarantino G
Growth Horm IGF Res; 2015 Feb; 25(1):28-33. PubMed ID: 25466907
[TBL] [Abstract][Full Text] [Related]
13. Peak and trough growth hormone concentrations have different associations with the insulin-like growth factor axis, body composition, and metabolic parameters.
Hindmarsh PC; Fall CH; Pringle PJ; Osmond C; Brook CG
J Clin Endocrinol Metab; 1997 Jul; 82(7):2172-6. PubMed ID: 9215290
[TBL] [Abstract][Full Text] [Related]
14. Gender differences in GH response to GHRH+ARG in lipodystrophic patients with HIV: a key role for body fat distribution.
Brigante G; Diazzi C; Ansaloni A; Zirilli L; Orlando G; Guaraldi G; Rochira V
Eur J Endocrinol; 2014 May; 170(5):685-96. PubMed ID: 24536088
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone releasing hormone plus arginine stimulation testing in young adults treated in childhood with cranio-spinal radiation therapy.
Ham JN; Ginsberg JP; Hendell CD; Moshang T
Clin Endocrinol (Oxf); 2005 May; 62(5):628-32. PubMed ID: 15853837
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone deficiency by growth hormone releasing hormone-arginine testing criteria predicts increased cardiovascular risk markers in normal young overweight and obese women.
Utz AL; Yamamoto A; Hemphill L; Miller KK
J Clin Endocrinol Metab; 2008 Jul; 93(7):2507-14. PubMed ID: 18445664
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone (GH) responses to GH-releasing hormone alone or combined with arginine in patients with adrenal incidentaloma: evidence for enhanced somatostatinergic tone.
Terzolo M; Bossoni S; Alí A; Doga M; Reimondo G; Milani G; Peretti P; Manelli F; Angeli A; Giustina A
J Clin Endocrinol Metab; 2000 Mar; 85(3):1310-5. PubMed ID: 10720081
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of growth hormone deficiency after pituitary surgery: the combined acipimox/GH-releasing hormone test.
van Dam PS; Dieguez C; Cordido F; de Vries WR; Veldhuyzen BF; van Thiel E; Casanueva FF; Koppeschaar HP
Clin Endocrinol (Oxf); 2003 Feb; 58(2):156-62. PubMed ID: 12580930
[TBL] [Abstract][Full Text] [Related]
19. Determinants of cardiovascular risk in 2589 hypopituitary GH-deficient adults - a KIMS database analysis.
Abs R; Feldt-Rasmussen U; Mattsson AF; Monson JP; Bengtsson BA; Góth MI; Wilton P; Koltowska-Häggström M
Eur J Endocrinol; 2006 Jul; 155(1):79-90. PubMed ID: 16793953
[TBL] [Abstract][Full Text] [Related]
20. Association between hypoadiponectinemia and cardiovascular risk factors in nonobese healthy adults.
Im JA; Kim SH; Lee JW; Shim JY; Lee HR; Lee DC
Metabolism; 2006 Nov; 55(11):1546-50. PubMed ID: 17046559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
